Efficacy of FK463, a (1,3)-β-D-glucan synthase inhibitor, in disseminated azole-resistant Candida albicans infection in mice

Antimicrobial Agents and Chemotherapy

Volumn 44, Issue 6, 2000, Pages 1728-1730

  Maesaki, Shigefumi ^a   Hossain, Mohammad Ashraf ^a   Miyazaki, Yoshitsugu ^a   Tomono, Kazunori ^a   Tashiro, Takayoshi ^a   Kohno, Shigeru ^a  

^a NAGASAKI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN B; AMPHOTERICIN B DEOXYCHOLATE; FLUCONAZOLE; GLUCAN SYNTHASE; ITRACONAZOLE; KETOCONAZOLE; MICAFUNGIN; PYRROLE DERIVATIVE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANDIDA ALBICANS; CANDIDIASIS; CONTROLLED STUDY; DRUG EFFICACY; DRUG POTENCY; MINIMUM INHIBITORY CONCENTRATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; SURVIVAL; TREATMENT OUTCOME;

ANIMALS; ANTIBIOTICS, ANTIFUNGAL; AZOLES; CANDIDA ALBICANS; CANDIDIASIS; DRUG RESISTANCE, MICROBIAL; LIPOPROTEINS; MICE; PEPTIDES, CYCLIC;

EID: 0034076997     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/AAC.44.6.1728-1730.2000     Document Type: Article

References (13)

1. Albertson, G. D., M. Niimi, R. D. Cannon, and H. F. Jenkinson. 1996. Multiple efflux mechanisms are involved in Candida albicans fluconazole resistance. Antimicrob. Agents Chemother. 40:2835-2841.
2. Hossain, M. A., T. Miyazaki, K. Mitsutake, H. Kakeya, Y. Yamamoto, K. Yanagihara, S. Kawamura, T. Otsubo, Y. Hirakata, T. Tashiro, and S. Kohno. 1997. Comparison between Wako-WB003 and Fungitec G tests for detection of (1,3)-β-D-glucan in systemic mycosis. J. Clin. Lab. Anal. 11:73-77.
3. Kurtz, M. B., E. M. Bernard, F. F. Edwards, J. A. Marrinan, J. Dropinski, C. M. Douglas, and D. Armstrong. 1995. Aerosol and parenteral pneumo-candins are effective in a rat model of pulmonary aspergillosis. Antimicrob. Agents Chemother. 39:1784-1789.
4. Law, D., C. B. Moore, H. M. Wardle, L. A. Ganguli, M. G. L. Keaney, and D. W. Denning. 1994. High prevalence of antifungal resistance in Candida spp. from patients with AIDS. J. Antimicrob. Chemother. 34:659-668.
5. Maesaki, S., P. Marichal, M. A. Hossain, D. Sanglard, H. Vanden Bossche, and S. Kohno. 1998. Synergic effects of tacrolimus and azole antifungal agents against azole-resistant Candida albicans strains. J. Antimicrob. Chemother. 42:747-753.
6. Miyazaki, T., S. Kohno, K. Mitsutake, S. Maesaki, K.-I. Tanaka, N. Ishikawa, and K. Hara. 1995. Plasma (1→3)-β-D-glucan and fungal antigenemia in patients with candidemia, aspergillosis, and cryptococcosis. J. Clin. Microbiol. 33:3115-3118.
7. National Committee for Clinical Laboratory Standards. 1997. Reference method for broth dilution antifungal susceptibility testing of yeasts. Approved standard M27-A. National Committee for Clinical Laboratory Standards, Villanova, Pa.
8. Obayashi, T., M. Yoshida, T. Mori, H. Goto, A. Yasuoka, H. Iwasaki, H. Teshima, S. Kohno, A. Horiuchi, A. Ito, H. Yamaguchi, K. Shimada, and T. Kawai. 1995. Plasma (1→3)-beta-D-glucan measurement in diagnosis of invasive deep mycosis and fungal febrile episodes. Lancet 345:17-20.
9. Pfaller, M. A., S. A. Messer, and S. Coffman. 1997. In vitro susceptibilities of clinical yeast isolates to a new echinocandin derivative, LY303366, and other antifungal agents. Antimicrob. Agents Chemother. 41:763-766.
10. Sanglard, D., K. Kuchler, F. Ischer, J. L. Pagani, M. Monod, and J. Bille. 1995. Mechanisms of resistance to azole antifungal agents in Candida albicans isolates from AIDS patients involve specific multidrug transporters. Antimicrob. Agents Chemother. 39:2378-2386.
11. Sanglard, D., F. Ischer, M. Monod, and J. Bille. 1996. Susceptibility of Candida albicans multidrug transporter mutants to various antifungal agents and other metabolic inhibitors. Antimicrob. Agents Chemother. 40:2300-2305.
12. Sternberg, S. 1994. The emerging fungal threat. Science 266:1632-1634.
13. Vanden Bossche, H., P. Marichal, and F. C. Odds. 1994. Molecular mechanisms of drug resistance in fungi. Trends Microbiol. 2:393-400.